Rutgers Health Begins Clinical Trial to Determine If B1 Can Slow Alzheimer's Disease
January 14, 2026
January 14, 2026
NEW BRUNSWICK, New Jersey, Jan. 14 (TNSjou) -- Rutgers University issued the following news:
* * *
Rutgers Health Begins Clinical Trial to Determine if B1 Can Slow Alzheimer's Disease
Researchers seek participants for a federally funded study to determine if benfotiamine, a synthetic version of thiamine (vitamin B1), can help slow disease progression
By Patti Zielinski
Researchers at Rutgers Robert Wood Johnson Medical School . . .
* * *
Rutgers Health Begins Clinical Trial to Determine if B1 Can Slow Alzheimer's Disease
Researchers seek participants for a federally funded study to determine if benfotiamine, a synthetic version of thiamine (vitamin B1), can help slow disease progression
By Patti Zielinski
Researchers at Rutgers Robert Wood Johnson Medical School . . .